The global antiseptic and disinfectant market size is projected to reach US$ 10.7 Bn by 2026, expanding at a compound annual growth rate (CAGR) of more than 6.7% from 2019 to 2026. High prevalence of Hospital-acquired Infections (HAIs), awareness about home hygiene and the need for disinfection, and increasing use of endoscope reprocesses and surgical units across the globe are anticipated to propel the product demand.
Increasing cases of HAIs due to lack of sanitation and precaution is one of the factors contributing to the market growth. For instance, as per the Centers for Disease Control and Prevention (CDC), around one in every 25 hospital patients suffer from at least one healthcare-associated infection every year. Such cases are expected to surge the demand for the product. This factor is anticipated to drive the market growth during the forecast period.
The report analyzes and forecasts the antiseptic and disinfectant market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of antiseptic and disinfectant, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major antiseptic and disinfectant companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of antiseptic and disinfectant upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of antiseptic and disinfectant and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global antiseptic and disinfectant market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the antiseptic and disinfectant market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of antiseptic and disinfectant market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
The report also profiles major players in the global antiseptic and disinfectant market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include 3M Company, Novartis Ag, Johnson & Johnson, STERIS plc, Getinge Group, Cardinal Health, Becton, Dickinson And Company, Whiteley Corporation, and Kimberly-Clark.
Global antiseptic and disinfectant market is segmented as below:
Global Antiseptic and Disinfectant Market, by Product, 2016?2026
Global Antiseptic and Disinfectant Market, by End-user, 2016?2026
Global Antiseptic and Disinfectant Market, by Geography, 2016?2026
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Chapter 1.Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2.Assumptions and Research Methodology
Chapter 3.Executive Summary : Global Antiseptic and Disinfectant Market
Chapter 4.Market Overview
4.1. Introduction
4.1.1. Modality Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Antiseptic and Disinfectant Market Analysis and Forecast, 2017–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.6. Market Outlook
4.7.Regulatory Scenarios
4.8. Distributor Analysis – by Company
4.9. List of Manufacturers (Classified by Disinfectants Production Capabilities)
4.9.1. High Level
4.9.2. Low Level
4.9.3. Middle Level
4.10. Pricing Comparison Analysis
4.10.1. By Product
4.10.2. By Company
Chapter 5.Global Antiseptic and Disinfectant Market Analysis and Forecast, by Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Value Forecast by Product, 2017–2026
5.3.1. Quaternary Ammonium Compounds
5.3.2. Chlorine Compounds
5.3.3. Alcohols
5.3.4. Aldehydes
5.3.5. Phenolic Compounds
5.3.6. Hydrogen Peroxide
5.3.7. Iodine
5.3.8. Silver
5.3.9. Others
5.4. Market Attractiveness by Product
Chapter 6.Global Antiseptic and Disinfectant Market Analysis and Forecast, by End-user
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast by End-user, 2017–2026
6.3.1. Healthcare Providers
6.3.2. Commercial Users
6.3.3. Domestic Users
6.4. Market Attractiveness by End-user
Chapter 7.Global Antiseptic and Disinfectant Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness, by Country/Region
Chapter 8.North America Antiseptic and Disinfectant Market Analysis and Forecast
8.1.Introduction
8.1.1. Key Findings
8.2.Market Value Forecast, by Product, 2017–2026
8.2.1. Quaternary Ammonium Compounds
8.2.2. Chlorine Compounds
8.2.3. Alcohols
8.2.4. Aldehydes
8.2.5. Phenolic Compounds
8.2.6. Hydrogen Peroxide
8.2.7. Iodine
8.2.8. Silver
8.2.9. Others
8.3.Market Value Forecast, by End-user, 2017–2026
8.3.1. Healthcare Providers
8.3.2. Commercial Users
8.3.3. Domestic Users
8.4.Market Value Forecast, by Country, 2017–2026
8.4.1. U.S.
8.4.2. Canada
8.5.Market Attractiveness Analysis
8.5.1. By Product
8.5.2. By End-user
8.5.3. By Country
Chapter 9.Europe Antiseptic and Disinfectant Market Analysis and Forecast
9.1.Introduction
9.1.1. Key Findings
9.2.Market Value Forecast, by Product, 2017–2026
9.2.1. Quaternary Ammonium Compounds
9.2.2. Chlorine Compounds
9.2.3. Alcohols
9.2.4. Aldehydes
9.2.5. Phenolic Compounds
9.2.6. Hydrogen Peroxide
9.2.7. Iodine
9.2.8. Silver
9.2.9. Others
9.3.Market Value Forecast, by End-user, 2017–2026
9.3.1. Healthcare Providers
9.3.2. Commercial Users
9.3.3. Domestic Users
9.4.Market Value Forecast, by Country, 2017–2026
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Spain
9.4.5. Italy
9.4.6. Russia
9.4.7. Rest of Europe
9.5.Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
Chapter 10.Asia Pacific Antiseptic and Disinfectant Market Analysis and Forecast
10.1.Introduction
10.1.1. Key Findings
10.2.Market Value Forecast, by Product, 2017–2026
10.2.1. Quaternary Ammonium Compounds
10.2.2. Chlorine Compounds
10.2.3. Alcohols
10.2.4. Aldehydes
10.2.5. Phenolic Compounds
10.2.6. Hydrogen Peroxide
10.2.7. Iodine
10.2.8. Silver
10.2.9. Others
10.3.Market Value Forecast, by End-user, 2017–2026
10.3.1. Healthcare Providers
10.3.2. Commercial Users
10.3.3. Domestic Users
10.4. Market Value Forecast, by Country, 2017–2026
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5.Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country
Chapter 11.Latin America Antiseptic and Disinfectant Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product, 2017–2026
11.2.1. Quaternary Ammonium Compounds
11.2.2. Chlorine Compounds
11.2.3. Alcohols
11.2.4. Aldehydes
11.2.5. Phenolic Compounds
11.2.6. Hydrogen Peroxide
11.2.7. Iodine
11.2.8. Silver
11.2.9. Others
11.3.Market Value Forecast, by End-user, 2017–2026
11.3.1. Healthcare Providers
11.3.2. Commercial Users
11.3.3. Domestic Users
11.4.Market Value Forecast, by Country, 2017–2026
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5.Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country
Chapter 12.Middle East & Africa Antiseptic and Disinfectant Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product, 2017–2026
12.2.1. Quaternary Ammonium Compounds
12.2.2. Chlorine Compounds
12.2.3. Alcohols
12.2.4. Aldehydes
12.2.5. Phenolic Compounds
12.2.6. Hydrogen Peroxide
12.2.7. Iodine
12.2.8. Silver
12.2.9. Others
12.3.Market Value Forecast, by End-user, 2017–2026
12.3.1. Healthcare Providers
12.3.2. Commercial Users
12.3.3. Domestic Users
12.4.Market Value Forecast, by Country, 2017–2026
12.4.1. GCC countries
12.4.2. South Africa
12.4.3. Israel
12.4.4. Rest of Middle East & Africa
12.5.Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country
Chapter 13.Competition Landscape
13.1.Market Player – Market Presence (2017)
13.1.1. Current Offerings
13.1.2. Strategy
13.2.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.2.1. Novartis AG
13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.1.2. Product Portfolio
13.2.1.3. SWOT Analysis
13.2.1.4. Financial Overview
13.2.1.5. Strategic Overview
13.2.2. 3M Company
13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2.2. Product Portfolio
13.2.2.3. SWOT Analysis
13.2.2.5. Strategic Overview
13.2.3. Johnson & Johnson
13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.3.2. Product Portfolio
13.2.3.3. SWOT Analysis
13.2.3.4. Financial Overview
13.2.3.5. Strategic Overview
13.2.4. STERIS plc
13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.4.2. Product Portfolio
13.2.4.3. SWOT Analysis
13.2.4.4. Financial Overview
13.2.4.5. Strategic Overview
13.2.5. Getinge Group
13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.5.2. Product Portfolio
13.2.5.3. SWOT Analysis
13.2.5.4. Financial Overview
13.2.5.5. Strategic Overview
13.2.6. Cardinal Health
13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.6.2. Product Portfolio
13.2.6.3. SWOT Analysis
13.2.6.4. Financial Overview
13.2.6.5. Strategic Overview
13.2.7. Becton, Dickinson And Company
13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.7.2. Product Portfolio
13.2.7.3. SWOT Analysis
13.2.7.4. Financial Overview
13.2.7.5. Strategic Overview
13.2.8. Whiteley Corporation
13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.8.2. Product Portfolio
13.2.8.3. SWOT Analysis
13.2.8.4. Financial Overview
13.2.8.5. Strategic Overview
13.2.9. Kimberly-Clark
13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.9.2. Product Portfolio
13.2.9.3. SWOT Analysis
13.2.9.4. Financial Overview
13.2.9.5. Strategic Overview
13.2.10. Others